.png){kind=icon}
.png){kind=icon}
Return
Latex-enhanced immunoturbidimetric assay of human HbA1c using a highly specific mouse anti-human monoclonal antibody (HbA1c-6C2)
.png){kind=icon}
PRE
AI
Z
X
X
W
C
J
DOI：10.1016/j.ab.2026.116117.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Background: Diabetes is an increasingly common metabolic disorder that is routinely diagnosed through clinical assessments, including fasting blood glucose and oral glucose tolerance testing. In recent years, a glycosylated form of hemoglobin (HbA1c) has emerged as a key diagnostic marker for diabetes. Various methods to detect HbA1c have been developed, each offering advantages and disadvantages. Methods: Here, we developed an anti-human monoclonal antibody (HbA1c-6C2) with high purity and specificity, which was applied to detect HbA1c in human blood samples using on a latex-enhanced immunoturbidimetric assay (LEIBA). Results: The LEIBA incorporating HbA1c-6C2 demonstrated excellent analytical performance. Linearity was confirmed across the HbA1c concentration range of 3.8% to 14.0%, with coefficients of variation below 1.5% for repeated detection at high and low concentration levels. Method comparison against high-performance liquid chromatography yielded a strong positive correlation (R2 = 0.99), indicating high concordance with established reference standards. Conclusion: The anti-human monoclonal antibody HbA1c-6C2, applied within a LEIBA, demonstrated strong linearity, high precision, stability, and accuracy for detecting HbA1c in human blood.
Keywords:
HbA1c
Monoclonal antibody
Latex-enhanced immunoturbidimetric assay
Methodological evaluation
Journal
IF:
2.5
Papers:
272
Citations:
3.3W
Organization
Cited Papers